Kiniksa Pharmaceuticals International, plc KNSA Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's comprehensive income (loss), net of tax, attributable to parent?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported comprehensive income (loss), net of tax, attributable to parent of $21.95M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's comprehensive income (loss), net of tax, attributable to parent increased by 157.1% year-over-year, from $8.54M to $21.95M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's comprehensive income (loss), net of tax, attributable to parent has grown at a -21.8% compound annual growth rate (CAGR), from -$157.96M to $59.14M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- Represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items like unrealized gains or losses. It provides a broader measure of financial performance than net income alone by capturing all recognized economic gains and losses. This metric is essential for evaluating the total economic impact of all financial activities on shareholder value.